Skip to main content

Table 1 Treatment results of representative pediatric solid tumors after the first relapse

From: Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol

Tumor types Number of cases MST (months) OS Ref.
% Year
Neuroblastoma 2266 20 5 [22]
357 10 14 10 [23]
Hepatoblastoma 59 12 43 3 [24]
Rhabdomyosarcoma 605 10 17 5 [25]
125 15 28 5 [26]
Ewing’s sarcoma 107 12 19 5 [27]
55 23 5 [28]
Osteosarcoma 43 15 35 3 [29]
Nephroblastoma 170 48 5 [30]
  1. MST median survival time, OS overall survival
\